← All stories
Markets
Is Oxford Nanopore Technologies (LSE:ONT) the Hardest Healthcare Name to Value Right Now?
Highlights Growth-stage life science names carry different rate sensitivity from established pharmaceutical groups Research funding cycles and instrument adoption drive sequencing platform demand Elevated UK borrowing costs form an unfavour…
Covered by 1 outlet
All coverage · 1 article